BlackRock HlthSc Op I
BlackRock HlthSc Op I (SHSSX)
This portfolio primarily directs its capital, dedicating a minimum of 80% of its total assets, towards equity holdings—chiefly common shares—of companies operating within the health sciences and closely related sectors. This comprehensive category includes businesses involved in medical equipment and supplies, healthcare service provision, biotechnology, and pharmaceutical research and manufacturing. The fund maintains a focused investment approach, ensuring that more than a quarter (over 25%) of its assets are committed to these health sciences industries. Additionally, it has the flexibility to include investments in companies based outside of the United States.
SHSSX Mutual Fund Chart & Stats
- Previous Close
- $75.20
- Sub-Category
- Sector-Specific
- Total Liabilities
- $82.87M
- Last Dividend Ex-Date
- Jul 22, 2026
- Expense Ratio
- 0.86%
- Holding Count
- 121
- Brand
- Blackrock Funds
- Dividend Yield
- (12.77%)
- Category
- Equity
- Total Assets
- 6.46B
- Shares Outstanding
- N/A
- 52-Week Range
- $65.37 - $77.19
SHSSX Mutual Fund News
SHSSX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| LLYEli Lilly And Company | 11.92% |
| JNJJohnson & Johnson | 8.03% |
| MRKMerck & Company | 5.56% |
| ABBVAbbvie | 5.07% |
| TMOThermo Fisher Scientific | 4.41% |
| UNHUnitedhealth Group Inc. | 4.33% |
| GILDGilead Sciences | 4.09% |
| AMGNAmgen Inc | 3.98% |
| VRTXVertex Pharmaceuticals Inc. | 3.33% |
| ABTAbbott Laboratories | 2.74% |
| Total | 53.47% |
Recently Viewed
No data currently available






